Clinical Trials Browser

Phase 2 × Interventional × Primary Immunodeficiency Diseases × Clear all

NCT03266653 2025-08-08

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Phase 2 Recruiting

Primary Immunodeficiency Diseases, Epstein-Barr Virus Infections